Acute myeloid leukemia, t(16;16)(p13.1;q22)

MONDO:0100374

Any acute myeloid leukemia that has the chromosomal anomaly t(16;16)(p13.1;q22). (A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.)

Also known as: AML, t(16;16)(p13.1;q22), AML, t(16;16)(p13.1;q22.1), AML, t(16;16)(p13.1q22), AML, t(16;16)(p13.1q22.1), AML, t(16;16)(p13;q22), AML, t(16;16)(p13q22)

3097 clinical trials for this condition and its sub-types, 10 tagged with Acute myeloid leukemia, t(16;16)(p13.1;q22) itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Acute myeloid leukemia (1194)

Including sub-types (3097) Tagged with Acute myeloid leukemia, t(16;16)(p13.1;q22) (10)

Trials to join now! 1 Not yet finished but already full! 3 Completed 6

New cocktail of 5 drugs targets tough leukemia

Disease control Recruiting now

This phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Sep 20, 2026 00:00 UTC

Acute myeloid leukemia, t(16;16)(p13.1;q22)

Where it sits in the disease tree

New cocktail of 5 drugs targets tough leukemia